Elevance Health Inc.ELVNYSE
Loading
Cash Flow Under PressureContracting
Percentile Rank43
3Y CAGR-24.1%
5Y CAGR-20.0%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
-24.1%/yr
vs +29.0%/yr prior
5Y CAGR
-20.0%/yr
Recent deceleration
Acceleration
-53.0pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
5 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.17B | -30.3% |
| 2024 | $4.55B | -32.7% |
| 2023 | $6.76B | -6.7% |
| 2022 | $7.25B | -0.4% |
| 2021 | $7.28B | -24.7% |
| 2020 | $9.67B | +94.0% |
| 2019 | $4.98B | +90.3% |
| 2018 | $2.62B | -22.8% |
| 2017 | $3.39B | +29.5% |
| 2016 | $2.62B | - |